Showing results (281-290 of 364) with videos related to
Sort By:
Pageof 37
Clinical Nuclear Medicine|October 3, 2012
Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinibDeniz Kahraman, Arne Holstein, Matthias Scheffler, et al.Angewandte Chemie (International Ed. in English)|October 21, 2024
CO Oxidation Catalyzed by Perovskites: The Role of Crystallographic Distortions Highlighted by Systematic Experiments and Artificial IntelligenceGiulia Bellini, Gregor Koch, Frank Girgsdies, et al.Cancer Immunology, Immunotherapy : CII|November 9, 2019
Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancersAndreas Mock, Stefanie Zschäbitz, Romy Kirsten, et al.Perfusion|August 11, 2017
International survey on the perioperative management of pulmonary endarterectomy: the perfusion perspectiveRoger D P Stanzel, Johannes Gehron, Matthias Wolff, et al.Physical Review Letters|December 17, 2013
Space-charge transfer in hybrid inorganic-organic systemsYong Xu, Oliver T Hofmann, Raphael Schlesinger, et al.Physical Review Letters|April 7, 2010
Alloy catalyst in a reactive environment: the example of ag-cu particles for ethylene epoxidationSimone Piccinin, Spiros Zafeiratos, Catherine Stampfl, et al.Chemical Science|September 30, 2017
Powder diffraction and crystal structure prediction identify four new coumarin polymorphsAlexander G Shtukenberg, Qiang Zhu, Damien J Carter, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinibCarsten Kobe, Matthias Scheffler, Arne Holstein, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2011
Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PETDeniz Kahraman, Matthias Scheffler, Thomas Zander, et al.Journal of Chemical Information and Modeling|September 7, 2018
AFLOW-CHULL: Cloud-Oriented Platform for Autonomous Phase Stability AnalysisCorey Oses, Eric Gossett, David Hicks, et al.Pageof 37